BMY241220P55000
- 0.31
- -0.18-36.73%
Bristol-Myers Squibb Newsroom
Bristol-Myers Squibb Shares Rise After Analyst Upgrade SAnd Positive Pipeline Outlook
Institutional Investors May Overlook Bristol-Myers Squibb Company's (NYSE:BMY) Recent US$5.9b Market Cap Drop as Long-term Gains Remain Positive
9 Health Care Stocks With Whale Alerts In Today's Session
Bristol Myers Squibb Terminates Agreements With Immatics Due To Ongoing Portfolio Prioritization Efforts Within BMS For Allogeneic Programs; Collaboration With BMS Under The 2019 Multi-Target TCR-T Strategic Collaboration Agreement Remains Ongoing
Tesla To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Monday
Bristol-Myers Squibb Analyst Ratings
Jefferies Upgrades Bristol-Myers Squibb(BMY.US) to Buy Rating, Raises Target Price to $70
Jefferies Upgrades Bristol-Myers Squibb to Buy From Hold, Adjusts Price Target to $70 From $63
Express News | Jefferies Financial has upgraded Bristol-Myers Squibb to a buy rating, with a Target Price of $70.
Bristol-Myers Squibb (NYSE:BMY) Will Pay A Larger Dividend Than Last Year At $0.62
Bristol-Myers Squibb Notified Century Therapeutics On Dec 12 To Terminate Collaboration Agreement, Effective March 12, 2025; Co To Evaluate Opportunities In AML And Multiple Myeloma In The Context Of The Ongoing Strategic Review Of Century's...
Express News | Century Therapeutics - to Evaluate Opportunities in Aml and Multiple Myeloma
Express News | Century Therapeutics - Termination Effective March 12, 2025
Express News | Century Therapeutics- Bms Notified Co on Dec 12 to Terminate Collaboration Agreement With Century Therapeutics
Express News | Bristol-Myers Squibb Co Files for Mixed Shelf; Size Not Disclosed - SEC Filing
Drug Price Hikes Unsupported By Evidence Cost US $815 Million: ICER Report
Bristol-Myers Squibb Hits 4-week Low
Why Bristol-Myers Squibb (BMY) Is Among the Best Long-Term Dividend Stocks to Invest in Right Now
CADL Stock Soars as Phase III Prostate Cancer Study Meets Primary Goal
Bristol-Myers Squibb To Go Ex-Dividend On January 3rd, 2025 With 0.62 USD Dividend Per Share
December 11th (Eastern Time) - $Bristol-Myers Squibb(BMY.US)$ is trading ex-dividend on January 3rd, 2025.Shareholders of record on January 3rd, 2025 will receive 0.62 USD dividend per share on